{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:19:44Z","timestamp":1790014784373,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874325"],"award-info":[{"award-number":["81874325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["18DZ1910604"],"award-info":[{"award-number":["18DZ1910604"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19DZ1910703"],"award-info":[{"award-number":["19DZ1910703"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19XD1400900"],"award-info":[{"award-number":["19XD1400900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109900","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T18:54:33Z","timestamp":1677610473000},"page":"109900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Identification of biomarkers that predict renal flare in childhood-onset lupus nephritis with mycophenolate acid"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5486-0319","authenticated-orcid":false,"given":"Ziwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-023X","authenticated-orcid":false,"given":"Zhiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2023.109900_b0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2017.02.001","article-title":"Expanding the B cell-centric view of systemic lupus erythematosus","volume":"38","author":"Morawski","year":"2017","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2023.109900_b0010","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","article-title":"European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2023.109900_b0015","doi-asserted-by":"crossref","unstructured":"H.J. Anders, M. Aringer, I. Bajema, J. Boletis, E. Frangou, F. A. Houssiau, J. Hollis, A. Karras, F. Marchiori, S.D. Marks, G. Moroni, M. Mosca, I. Parodis, M. Praga, M. Schneider, J.S. Smolen, V. Tesar, M. Trachana, RF. van Vollenhoven, AE. Voskuyl, YKO. Teng, B. van Leew, G. Bertsias, D. Jayne, D.T. Boumpas. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis, Ann. Rheum. Dis. 79 (6) (2020) 713-723.","DOI":"10.1136\/annrheumdis-2020-216924"},{"issue":"6","key":"10.1016\/j.intimp.2023.109900_b0020","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00467-020-04686-1","article-title":"Kidney outcomes for children with lupus nephritis","volume":"36","author":"Oni","year":"2021","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109900_b0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/1756-185X.12419","article-title":"Childhood onset systemic lupus erythematosus: how is it different from adult SLE?","volume":"18","author":"Aggarwal","year":"2015","journal-title":"Int. J. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.intimp.2023.109900_b0030","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.4049\/jimmunol.1003319","article-title":"Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation","volume":"187","author":"Karnell","year":"2011","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109900_b0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","article-title":"Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology","volume":"43","author":"Bergan","year":"2021","journal-title":"Ther. Drug. Monit."},{"issue":"1","key":"10.1016\/j.intimp.2023.109900_b0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ndt\/gfy026","article-title":"The utility of trough mycophenolic acid levels for the management of lupus nephritis","volume":"34","author":"Pourafshar","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.intimp.2023.109900_b0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2125.2011.04140.x","article-title":"Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus","volume":"73","author":"Sherwin","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109900_b0050","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bcp.12392","article-title":"Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring","volume":"78","author":"Woillard","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109900_b0055","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/ndt\/gfu184","article-title":"To TDM or not to TDM in lupus nephritis patients treated with MMF?","volume":"30","author":"van Gelder","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.intimp.2023.109900_b0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/FTD.0000000000000223","article-title":"Therapeutic drug monitoring of mycophenolic acid in lupus nephritis: A review of current literature","volume":"37","author":"\u0141uszczy\u0144ska","year":"2015","journal-title":"Ther. Drug. Monit."},{"issue":"4","key":"10.1016\/j.intimp.2023.109900_b0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.semarthrit.2010.05.007","article-title":"Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus","volume":"40","author":"Sagcal-Gironella","year":"2011","journal-title":"Semin. Arthritis. Rheum."},{"issue":"2","key":"10.1016\/j.intimp.2023.109900_b0070","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00467-020-04733-x","article-title":"Mycophenolic acid area under the concentration-time curve is associated with therapeutic response in childhood-onset lupus nephritis","volume":"36","author":"Godron-Dubrasquet","year":"2021","journal-title":"Pediatr. Nephrol."},{"issue":"9","key":"10.1016\/j.intimp.2023.109900_b0075","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.intimp.2023.109900_b0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40272-021-00457-z","article-title":"An Update on the management of childhood-onset systemic lupus erythematosus","volume":"23","author":"Trindade","year":"2021","journal-title":"Paediatr. Drugs."},{"issue":"2","key":"10.1016\/j.intimp.2023.109900_b0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"International Society of Nephrology Working Group on the Classification of Lupus Nephritis, Renal Pathology Society Working Group on the Classification of Lupus Nephritis, The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.intimp.2023.109900_b0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00467-018-4067-3","article-title":"Estimating glomerular filtration rate in children: evaluation of creatinine- and cystatin C-based equations","volume":"34","author":"Salvador","year":"2019","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109900_b0095","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109900_b0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00467-021-05164-y","article-title":"Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis","volume":"37","author":"Qiu","year":"2022","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109900_b0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2215\/CJN.05040513","article-title":"Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis","volume":"9","author":"Parikh","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.intimp.2023.109900_b0110","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2215\/CJN.00340118","article-title":"Clinical pharmacokinetics in kidney disease: fundamental principles","volume":"13","author":"Lea-Henry","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109900_b0115","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/bcp.14590","article-title":"Population pharmacokinetics of mycophenolic acid in paediatric patients","volume":"87","author":"Rong","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109900_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.924766","article-title":"The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus","volume":"13","author":"Qiu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109900_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107627","article-title":"French Society of Pharmacology and Therapeutics, Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment","volume":"215","author":"Stanke-Labesque","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2023.109900_b0130","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1111\/bcp.15372","article-title":"A systematic review on disease-drug-drug interactions with immunomodulating drugs: A critical appraisal of risk assessment and drug labelling","volume":"88","author":"de Jong","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109900_b0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/FPC.0000000000000010","article-title":"PharmGKB summary: mycophenolic acid pathway","volume":"24","author":"Lamba","year":"2014","journal-title":"Pharmacogenet. Genomics."},{"issue":"4","key":"10.1016\/j.intimp.2023.109900_b0140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bcp.12086","article-title":"Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)","volume":"76","author":"Knights","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109900_b0145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1124\/dmd.105.007435","article-title":"Expression of UDP-glucuronosyltransferase isoform mRNAs during inflammation and infection in mouse liver and kidney","volume":"34","author":"Richardson","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.intimp.2023.109900_b0150","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cpt.1115","article-title":"International Transporter Consortium, Disease-associated changes in drug transporters may impact the pharmacokinetics and\/or toxicity of drugs: A white paper from the international transporter consortium","volume":"104","author":"Evers","year":"2018","journal-title":"Clin, Pharmacol, Ther."},{"issue":"3","key":"10.1016\/j.intimp.2023.109900_b0155","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1046\/j.1523-1755.2002.00531.x","article-title":"Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation","volume":"62","author":"Cattaneo","year":"2002","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.intimp.2023.109900_b0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/B:MOLE.0000043582.35335.ff","article-title":"Stimulation of transcriptional expression of human UDP-glucuronosyltransferase 1A1 by dexamethasone","volume":"31","author":"Kanou","year":"2004","journal-title":"Mol Biol Rep."},{"issue":"9","key":"10.1016\/j.intimp.2023.109900_b0165","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/0961203320931567","article-title":"Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis","volume":"29","author":"Romano-Aguilar","year":"2020","journal-title":"Lupus."},{"issue":"4","key":"10.1016\/j.intimp.2023.109900_b0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00003088-200847040-00005","article-title":"Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies","volume":"47","author":"Zahr","year":"2008","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.intimp.2023.109900_b0175","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/clpt.2014.140","article-title":"Exposure to mycophenolic acid better predicts immunosuppressive efficacy than exposure to calcineurin inhibitors in renal transplant patients","volume":"96","author":"Daher Abdi","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.intimp.2023.109900_b0180","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/art.27495","article-title":"Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil","volume":"62","author":"Zahr","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.intimp.2023.109900_b0185","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ki.2010.170","article-title":"Pharmacokinetics of mycophenolic acid in severe lupus nephritis","volume":"78","author":"Lertdumrongluk","year":"2010","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.intimp.2023.109900_b0190","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/FTD.0000000000000031","article-title":"Pharmacokinetics of concentration-controlled mycophenolate mofetil in proliferative lupus nephritis: an observational cohort study","volume":"36","author":"Alexander","year":"2014","journal-title":"Ther. Drug. Monit."},{"issue":"5","key":"10.1016\/j.intimp.2023.109900_b0195","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/bcp.12678","article-title":"Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis","volume":"80","author":"Abd Rahman","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109900_b0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2215\/CJN.09430915","article-title":"antibodies, and more","volume":"11","author":"Hoffman","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109900_b0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1567-5769(02)00210-2","article-title":"Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells","volume":"3","author":"Jonsson","year":"2003","journal-title":"Int. Immunopharmacol."},{"issue":"14","key":"10.1016\/j.intimp.2023.109900_b0210","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1177\/09612033211061475","article-title":"Something new about prognostic factors for lupus nephritis? A systematic review","volume":"30","author":"Rodr\u00edguez-Almaraz","year":"2021","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.intimp.2023.109900_b0215","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1681\/ASN.2016060670","article-title":"Prognostic value of serum biomarkers of autoimmunity for recurrence of IgA nephropathy after kidney transplantation","volume":"28","author":"Berthoux","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2023.109900_b0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.intimp.2018.10.044","article-title":"Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy","volume":"66","author":"Liu","year":"2019","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:03:56Z","timestamp":1761588236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923002205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":44,"alternative-id":["S1567576923002205"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109900","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of biomarkers that predict renal flare in childhood-onset lupus nephritis with mycophenolate acid","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109900"}}